Brief: Annexin Says Annexin A5 May Be Relevant As Treatment For Covid-19

Annexin Pharmaceuticals AB (publ)

17/06/2020 14:34

June 17 (Reuters) - Annexin Pharmaceuticals AB (publ)
 ANNX.ST :
    * DATA FROM A RECENT PATIENT STUDY AND FROM PRECLINICAL
STUDIES
SHOWS THAT THE PROTEIN ANNEXIN A5 MAY BE RELEVANT AS A TREATMENT
FOR PATIENTS WITH COVID-19

Source text for Eikon:  ID:nWkr1GLDZF 
Further company coverage:  ANNX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))